Microdose tirzepatide may be a good fit for patients who want a gentle dual-pathway option, are concerned about side effects, have previously experienced nausea on GLP-1 medications, or want gradual weight management support
Key timeline for Eli Lillys orforglipron: The approval of the first oral GLP-1 pill for weight loss expands the treatment landscape for obesity
5-HTP (5-Hydroxytryptophan) addresses the often-overlooked emotional and psychological aspects of weight management
GLP1s, peptides, NAD, and regenerative techniques can be transformative when used thoughtfully
Results Case report A 35-year-old female with GH-secreting pituitary tumors was treated with surgery and medical therapy using the first-generation SSA, octreotide, and the D2 agonist, cabergoline